Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

Eric Bouteiller

Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

科研成果: 工作论文

162 下载量 (Pure)

摘要

During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.

源语言	英语
州	已出版 - 3月 2022

Source

China Europe International Business School (CEIBS)

访问文件

046-Bouteiller, Eric_Mar 2022_0最终出版的版本, 318 KB许可: CC BY-NC-ND

https://www.ceibs.edu/sites/portal.prod.dpmgr.ceibs.edu/files/2023-02/046-Bouteiller%2C%20Eric_Mar%202022_0.pdf许可: CC BY-NC-ND

OpenUrl 可用性

全文

引用此

@techreport{78810797933e4b3d8505a819c170af87,

title = "Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)",

abstract = "During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.",

keywords = "healthcare, health",

author = "Eric Bouteiller",

year = "2022",

month = mar,

language = "English",

type = "WorkingPaper",

}

TY - UNPB

T1 - Rare Diseases Are Not Rare in China

T2 - What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

AU - Bouteiller, Eric

PY - 2022/3

Y1 - 2022/3

N2 - During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.

AB - During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.

KW - healthcare

KW - health

M3 - Working paper

BT - Rare Diseases Are Not Rare in China

ER -

Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

摘要

Source

访问文件

OpenUrl 可用性

指纹

引用此